20. July 2026

Real-Time Monitoring vs. Standard Tracking: What Pharmaceutical Companies Really Need

Smart Logistics: Real-Time Insights into the Cold Chain

The requirements for pharmaceutical logistics have risen significantly in recent years. Particularly in GDP-regulated cold chain logistics, on-time delivery alone is no longer sufficient. Ensuring continuous compliance with defined temperature ranges along the entire supply chain is critical.

At MSK, this specifically affects the storage and distribution of pharmaceuticals and healthcare products in the ranges of +2 to +8 °C and +15 to +25 °C. These temperature windows are part of the product specification and must be maintained under validated conditions.

Against this background, a central question arises: Is standard tracking sufficient to ensure compliance, or is real-time monitoring required?

Standard Tracking in Everyday Pharmaceutical Logistics

Standard tracking is well-established in many supply chains. Shipments are scanned and documented at designated points. This works reliably as long as transports proceed according to plan.

In practice, however, a clear limitation becomes apparent. Temperature deviations are frequently only detected at the end of the journey. While the shipment is then fully documented, it no longer meets the quality requirements.

Especially with temperature-sensitive pharmaceuticals, this has direct consequences. Even short interruptions in the cold chain often go unnoticed. The problem lies not within the documentation itself, but rather in the lack of transparency during transit.

Real-Time Monitoring as a Component of Quality Assurance

Real-time monitoring expands classical tracking structures by adding continuous condition data. IoT-based sensors record temperature, location, and in some cases, shocks during the entire transport.

Particularly in cold chain logistics, this form of surveillance is a central component of modern quality assurance systems. It supports compliance with GDP requirements and enables risk-based management of transports.

Distribution to medical practices and hospitals often takes place within finely distributed transport networks with short lead times. Numerous potential deviations arise in these processes, for example, due to delays, transshipments, or external influences.

Real-time monitoring makes such deviations immediately visible. In the event of temperature violations, defined SOP-based measures can be initiated. This increases process control and reduces the risk of product loss.

Insights from Operational Practice

The difference becomes clearly visible in day-to-day operations. A typical example is the delivery of products in the +2 to +8 °C range to a medical practice. The goods are transported in validated packaging. Dispatch and delivery are documented.

Only when the data logger is evaluated does it become apparent that a temperature deviation occurred during transport. The goods can therefore no longer be released for use.

With real-time monitoring, the deviation would have been visible during transit. The team could have intervened, for instance, via prioritized delivery. This difference determines whether the products can still be used.

“In cold chain logistics, it’s not about collecting data, but about making decisions at the right time,” says Harald Rohatsch, Chief Operating Officer Logistics of the MSK Pharma Group. “Standard tracking shows what happened. Real-time monitoring shows what is happening right now and allows for immediate intervention.”

The expectations of recipients have also risen. Medical practices and hospitals must be able to rely on the quality. “Our customers expect every shipment to meet the defined requirements. Real-time transparency helps us actively ensure this quality,” says Rohatsch.

When Which Approach Makes Sense

Not every shipment requires real-time monitoring. The critical factor is the risk profile. In the +2 to +8 °C range, tolerances are tight. Deviations directly impact product quality. Here, real-time monitoring is increasingly becoming the standard.

In the +15 to +25 °C range, standard tracking may be sufficient under stable conditions, such as short transport routes.

In practice, a combination proves successful. Standard tracking forms the baseline. Real-time monitoring is deployed selectively where risks need to be mitigated.

Quality is the Result of Controlled Processes

The requirements for cold chain logistics continue to increase. Pure traceability is often no longer enough. Real-time monitoring enables active control of the supply chain. Risks become visible before they lead to deviations.

As a pharmaceutical full-service provider, we assume operational responsibility in cold chain logistics to ensure that temperature-sensitive pharmaceuticals and healthcare products in the ranges of +2 to +8 °C and +15 to +25 °C are stored and transported under validated conditions, and that specified requirements are met along the entire supply chain.

Through the combination of structured tracking, targeted use of real-time monitoring, and clearly defined processes for deviations, we ensure that risks are detected early and processed transparently. This guarantees that medical practices and hospitals receive reliably documented quality as a foundation for the further use of the products.